Literature DB >> 19933765

Multi-informant reports of psychiatric symptoms among high-functioning adolescents with Asperger syndrome or autism.

Tuula Hurtig1, Sanna Kuusikko, Marja-Leena Mattila, Helena Haapsamo, Hanna Ebeling, Katja Jussila, Leena Joskitt, David Pauls, Irma Moilanen.   

Abstract

The aim of the study was to examine psychiatric symptoms in high-functioning adolescents with autism spectrum disorders reported by multiple informants. Forty-three 11- to 17-year-old adolescents with Asperger syndrome (AS) or high-functioning autism (HFA) and 217 typically developed adolescents completed the Youth Self-Report (YSR), while their parents completed the Child Behavior Checklist (CBCL). Teachers of adolescents with AS/HFA completed the Teacher Report Form (TRF). The informants reported significantly more psychiatric symptoms, especially withdrawn, anxious/depressed, social and attention problems, in adolescents with AS/HFA than in controls. In contrast to findings in the general population, the psychiatric problems of adolescents with AS/HFA are well acknowledged by multiple informants, including self-reports. However, anxiety and depressive symptoms were more commonly reported by adolescents with AS/HFA and their teachers than their parents, indicating that some emotional distress may be hidden from their parents.

Entities:  

Mesh:

Year:  2009        PMID: 19933765     DOI: 10.1177/1362361309335719

Source DB:  PubMed          Journal:  Autism        ISSN: 1362-3613


  49 in total

1.  Psychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challenges.

Authors:  Luigi Mazzone; Liliana Ruta; Laura Reale
Journal:  Ann Gen Psychiatry       Date:  2012-06-25       Impact factor: 3.455

2.  Self-reported social impairments predict depressive disorder in adults with autism spectrum disorder.

Authors:  Talena C Day; Kathryn A McNaughton; Adam J Naples; James C McPartland
Journal:  Autism       Date:  2019-06-25

3.  Using self- and parent-reports to test the association between peer victimization and internalizing symptoms in verbally fluent adolescents with ASD.

Authors:  Ryan E Adams; Bridget K Fredstrom; Amie W Duncan; Lauren J Holleb; Somer L Bishop
Journal:  J Autism Dev Disord       Date:  2014-04

4.  Emotional and behavioural problems in children with autism spectrum disorder.

Authors:  Morag Maskey; Frances Warnell; Jeremy R Parr; Ann Le Couteur; Helen McConachie
Journal:  J Autism Dev Disord       Date:  2013-04

5.  Depressive and anxiety symptom trajectories from school age through young adulthood in samples with autism spectrum disorder and developmental delay.

Authors:  Katherine Gotham; Steven M Brunwasser; Catherine Lord
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-02-17       Impact factor: 8.829

Review 6.  Characterization of depression in children with autism spectrum disorders.

Authors:  Katherine M Magnuson; John N Constantino
Journal:  J Dev Behav Pediatr       Date:  2011-05       Impact factor: 2.225

7.  Changes in prevalence of autism spectrum disorders in 2001-2011: findings from the Stockholm youth cohort.

Authors:  Selma Idring; Michael Lundberg; Harald Sturm; Christina Dalman; Clara Gumpert; Dheeraj Rai; Brian K Lee; Cecilia Magnusson
Journal:  J Autism Dev Disord       Date:  2015-06

8.  Informant agreement for youth with autism spectrum disorder or intellectual disability: a meta-analysis.

Authors:  Elizabeth A Stratis; Luc Lecavalier
Journal:  J Autism Dev Disord       Date:  2015-04

9.  Associations Among Symptoms of Autism, Symptoms of Depression and Executive Functions in Children with High-Functioning Autism: A 2 Year Follow-Up Study.

Authors:  Per Normann Andersen; Erik Winther Skogli; Kjell Tore Hovik; Jens Egeland; Merete Øie
Journal:  J Autism Dev Disord       Date:  2015-08

10.  Rumination and perceived impairment associated with depressive symptoms in a verbal adolescent-adult ASD sample.

Authors:  Katherine Gotham; Somer L Bishop; Steven Brunwasser; Catherine Lord
Journal:  Autism Res       Date:  2014-05-06       Impact factor: 5.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.